Oral or parenteral administration of replication-deficient adenoviruses expressing the measles virus haemagglutinin and fusion proteins: protective immune responses in rodents

The genes encoding the measles virus (MV) haemagglutinin (H) and fusion (F) proteins were placed under the control of the human cytomegalovirus immediate early promoter in a replication-deficient adenovirus vector. Immunofluorescence and radioimmune precipitation demonstrated the synthesis of each p...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Journal of general virology Ročník 79 ( Pt 5); s. 1027
Hlavní autoři: Fooks, A R, Jeevarajah, D, Lee, J, Warnes, A, Niewiesk, S, ter Meulen, V, Stephenson, J R, Clegg, J C
Médium: Journal Article
Jazyk:angličtina
Vydáno: England 01.05.1998
Témata:
ISSN:0022-1317
On-line přístup:Zjistit podrobnosti o přístupu
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
Abstract The genes encoding the measles virus (MV) haemagglutinin (H) and fusion (F) proteins were placed under the control of the human cytomegalovirus immediate early promoter in a replication-deficient adenovirus vector. Immunofluorescence and radioimmune precipitation demonstrated the synthesis of each protein and biological activity was confirmed by the detection of haemadsorption and fusion activities in infected cells. Oral as well as parenteral administration of the H-expressing recombinant adenovirus elicited a significant protective response in mice challenged with MV. While the F-expressing adenovirus failed to protect mice, cotton rats immunized with either the H- or F-expressing recombinant showed reduced MV replication in the lungs. Antibodies elicited in mice following immunization with either recombinant had no in vitro neutralizing activity, suggesting a protective mechanism involving a cell-mediated immune response. This study demonstrates the feasibility of using oral administration of adenovirus recombinants to induce protective responses to heterologous proteins.
AbstractList The genes encoding the measles virus (MV) haemagglutinin (H) and fusion (F) proteins were placed under the control of the human cytomegalovirus immediate early promoter in a replication-deficient adenovirus vector. Immunofluorescence and radioimmune precipitation demonstrated the synthesis of each protein and biological activity was confirmed by the detection of haemadsorption and fusion activities in infected cells. Oral as well as parenteral administration of the H-expressing recombinant adenovirus elicited a significant protective response in mice challenged with MV. While the F-expressing adenovirus failed to protect mice, cotton rats immunized with either the H- or F-expressing recombinant showed reduced MV replication in the lungs. Antibodies elicited in mice following immunization with either recombinant had no in vitro neutralizing activity, suggesting a protective mechanism involving a cell-mediated immune response. This study demonstrates the feasibility of using oral administration of adenovirus recombinants to induce protective responses to heterologous proteins.The genes encoding the measles virus (MV) haemagglutinin (H) and fusion (F) proteins were placed under the control of the human cytomegalovirus immediate early promoter in a replication-deficient adenovirus vector. Immunofluorescence and radioimmune precipitation demonstrated the synthesis of each protein and biological activity was confirmed by the detection of haemadsorption and fusion activities in infected cells. Oral as well as parenteral administration of the H-expressing recombinant adenovirus elicited a significant protective response in mice challenged with MV. While the F-expressing adenovirus failed to protect mice, cotton rats immunized with either the H- or F-expressing recombinant showed reduced MV replication in the lungs. Antibodies elicited in mice following immunization with either recombinant had no in vitro neutralizing activity, suggesting a protective mechanism involving a cell-mediated immune response. This study demonstrates the feasibility of using oral administration of adenovirus recombinants to induce protective responses to heterologous proteins.
The genes encoding the measles virus (MV) haemagglutinin (H) and fusion (F) proteins were placed under the control of the human cytomegalovirus immediate early promoter in a replication-deficient adenovirus vector. Immunofluorescence and radioimmune precipitation demonstrated the synthesis of each protein and biological activity was confirmed by the detection of haemadsorption and fusion activities in infected cells. Oral as well as parenteral administration of the H-expressing recombinant adenovirus elicited a significant protective response in mice challenged with MV. While the F-expressing adenovirus failed to protect mice, cotton rats immunized with either the H- or F-expressing recombinant showed reduced MV replication in the lungs. Antibodies elicited in mice following immunization with either recombinant had no in vitro neutralizing activity, suggesting a protective mechanism involving a cell-mediated immune response. This study demonstrates the feasibility of using oral administration of adenovirus recombinants to induce protective responses to heterologous proteins.
Author Jeevarajah, D
Clegg, J C
Lee, J
Fooks, A R
ter Meulen, V
Niewiesk, S
Stephenson, J R
Warnes, A
Author_xml – sequence: 1
  givenname: A R
  surname: Fooks
  fullname: Fooks, A R
  email: anthony.fooks@camr.org.uk
  organization: Centre for Applied Microbiology and Research, Porton Down, Salisbury, UK. anthony.fooks@camr.org.uk
– sequence: 2
  givenname: D
  surname: Jeevarajah
  fullname: Jeevarajah, D
– sequence: 3
  givenname: J
  surname: Lee
  fullname: Lee, J
– sequence: 4
  givenname: A
  surname: Warnes
  fullname: Warnes, A
– sequence: 5
  givenname: S
  surname: Niewiesk
  fullname: Niewiesk, S
– sequence: 6
  givenname: V
  surname: ter Meulen
  fullname: ter Meulen, V
– sequence: 7
  givenname: J R
  surname: Stephenson
  fullname: Stephenson, J R
– sequence: 8
  givenname: J C
  surname: Clegg
  fullname: Clegg, J C
BackLink https://www.ncbi.nlm.nih.gov/pubmed/9603317$$D View this record in MEDLINE/PubMed
BookMark eNo9UMtOwzAQ9KGotMAXICSfuBn8SJOYG6p4SZV6gXPkxJvWKLGD7VTwVfwi7kOcdnd2dma0czSxzgJC14zeMSrlPaWcEyZYQQpJFoRRXkzQ7B89R_MQPillWbYopmgqcyoSPEO_a6867DwelAcbYT8p3RtrQvQqGmexa7GHoTPNYSQaWtOYxE08sG5n_BggYPgePIRg7AbHLeAeVOgSfFjjrYJebTbdGJOwxcpq3I5hLz54F8HY8HDsmmh2gE3fjxaSaxic3YunG--SWwyX6KxVXYCrU71AH89P78tXslq_vC0fV6QReRZJzUCXZVvTXJdapsgyL6TWedkKAbrQgrdKLHidZVK3QmuQIv2D1znnlOaS8Qt0e9RNsb5GCLHqTWig65QFN4aqkKVkZZkn4s2JONY96Grwplf-pzp9mP8BSGGElA
CitedBy_id crossref_primary_10_3390_v14030520
crossref_primary_10_1128_CMR_17_2_465_493_2004
crossref_primary_10_1016_j_apsb_2024_08_026
crossref_primary_10_1006_viro_2001_1240
crossref_primary_10_1016_S1359_6446_00_01600_7
crossref_primary_10_1111_tbed_13936
crossref_primary_10_1016_j_ymthe_2004_07_013
crossref_primary_10_1186_1743_422X_8_268
crossref_primary_10_1006_viro_2001_0945
crossref_primary_10_1016_S0020_7519_03_00062_6
crossref_primary_10_1016_S0264_410X_00_00452_7
crossref_primary_10_1128_JVI_74_19_9083_9089_2000
crossref_primary_10_1016_j_micinf_2005_05_023
crossref_primary_10_1016_j_vaccine_2010_09_055
crossref_primary_10_1016_S0165_2478_98_00123_0
crossref_primary_10_1586_14760584_1_2_151
crossref_primary_10_1016_S0928_0197_98_00038_5
ContentType Journal Article
DBID CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1099/0022-1317-79-5-1027
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: 7X8
  name: MEDLINE - Academic
  url: https://search.proquest.com/medline
  sourceTypes: Aggregation Database
DeliveryMethod no_fulltext_linktorsrc
Discipline Biology
ExternalDocumentID 9603317
Genre Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID ---
-~X
.55
.GJ
186
18M
2WC
39C
3O-
4.4
53G
5GY
5RE
AAJMC
ABDNZ
ACBTR
ACGFO
ACPEE
ACYGS
ADBBV
ADCDP
ADCOW
AEILP
AENEX
AFFNX
AGCDD
AI.
AJKYU
ALMA_UNASSIGNED_HOLDINGS
BAWUL
C1A
CGR
CJ0
CS3
CUY
CVF
DIK
DU5
E3Z
EBS
ECM
EIF
EJD
F5P
FRP
GX1
H13
IH2
K-O
L7B
NPM
OHT
OK1
P2P
PKN
RGM
TR2
VH1
W8F
WH7
WHG
WOQ
X7M
Y6R
YKV
YSK
ZGI
~KM
7X8
ID FETCH-LOGICAL-c364t-b1ed88fb06d8d9def9679dd68f33ed7d32fa352b449df3dde933312b622006912
IEDL.DBID 7X8
ISICitedReferencesCount 31
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000073436400008&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 0022-1317
IngestDate Fri Jul 11 06:55:53 EDT 2025
Wed Feb 19 01:18:20 EST 2025
IsPeerReviewed true
IsScholarly true
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c364t-b1ed88fb06d8d9def9679dd68f33ed7d32fa352b449df3dde933312b622006912
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
PMID 9603317
PQID 79891886
PQPubID 23479
ParticipantIDs proquest_miscellaneous_79891886
pubmed_primary_9603317
PublicationCentury 1900
PublicationDate 1998-05-01
PublicationDateYYYYMMDD 1998-05-01
PublicationDate_xml – month: 05
  year: 1998
  text: 1998-05-01
  day: 01
PublicationDecade 1990
PublicationPlace England
PublicationPlace_xml – name: England
PublicationTitle Journal of general virology
PublicationTitleAlternate J Gen Virol
PublicationYear 1998
SSID ssj0014457
Score 1.709393
Snippet The genes encoding the measles virus (MV) haemagglutinin (H) and fusion (F) proteins were placed under the control of the human cytomegalovirus immediate early...
SourceID proquest
pubmed
SourceType Aggregation Database
Index Database
StartPage 1027
SubjectTerms Adenoviridae - physiology
Administration, Oral
Animals
Antibodies, Viral - immunology
Cell Line
Cell Line, Transformed
Defective Viruses - physiology
Female
Genetic Vectors
Hemagglutinins, Viral - genetics
Hemagglutinins, Viral - immunology
Humans
Injections, Intraperitoneal
Measles - prevention & control
Measles Vaccine - immunology
Measles virus - immunology
Mice
Mice, Inbred BALB C
Mice, Inbred C3H
Rats
Sigmodontinae
Viral Fusion Proteins - genetics
Viral Fusion Proteins - immunology
Virus Replication
Title Oral or parenteral administration of replication-deficient adenoviruses expressing the measles virus haemagglutinin and fusion proteins: protective immune responses in rodents
URI https://www.ncbi.nlm.nih.gov/pubmed/9603317
https://www.proquest.com/docview/79891886
Volume 79 ( Pt 5)
WOSCitedRecordID wos000073436400008&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText
inHoldings 1
isFullTextHit
isPrint
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV07b9swECbSpAWyNOnDiJsXh66ELVISySJAUAQ1MiRuhgTwZlDmyRVQU65kG-2vyl_snWSl6FB0yCJAIikSutPHI-_4HWMf42yo4kyCSHyaC2IAExmoRFiibvdu6DU0kr7R47GZTOzdDrvozsJQWGWHiQ1Q-3JGe-QDbY2NjEkvlz8E5Ywi3-o2gcYLtqfQkCGd1pM_PoQ4TnTHFR7hNNlxDlk7eHomtBXExCn1vy3MZqYZHTxvjIfs9dbC5J9blXjDdiC8Za_anJO_3rHHrxWWlhWn0HP6qnjn_mLQ5WXOK3jyawsPxDKBdbEehHJTVOsaag4_2xjaMOdoRPIFuPo7Pm6K-TcHCzefk1qHInAXPM_XtDHHG2KIItSf-JYiAuGWF3RKBbDXJmAX34JtENkpyOM9exh9ub-6FtusDWKm0nglsgi8MXk2TL3xFodoU229T02uFHjtlcwdWn1ZHFufK0RXq5SKZJZK2t2wkeyx3VAGOGJcz7RNvQRpaNlnvEuMIwCRoGWcWOiz804OU_wryNXhApTretpJos96rSiny5a8Y4orNuxOf_hv02O2354_pODGE7aXIxzAKXs526yKujprdA2v47vb37wF47E
linkProvider ProQuest
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Oral+or+parenteral+administration+of+replication-deficient+adenoviruses+expressing+the+measles+virus+haemagglutinin+and+fusion+proteins%3A+protective+immune+responses+in+rodents&rft.jtitle=Journal+of+general+virology&rft.au=Fooks%2C+A+R&rft.au=Jeevarajah%2C+D&rft.au=Lee%2C+J&rft.au=Warnes%2C+A&rft.date=1998-05-01&rft.issn=0022-1317&rft.volume=79+%28+Pt+5%29&rft.spage=1027&rft_id=info:doi/10.1099%2F0022-1317-79-5-1027&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0022-1317&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0022-1317&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0022-1317&client=summon